IP Library Granted Patent US 12,324,821
Granted Patent B2
US 12,324,821 · App. 16/259,074 · Granted Jun 10, 2025

Hair loss treatment compositions and methods of making and using same

Inventors: Denny Esco Stottlemyre (Mannsville, OK); Ronald Dale Reynolds (Kingston, OK)
Assignee: The Beauty Cartel, LLC
A61K36/14A61K8/64A61K8/922A61K8/9789A61K31/352A61K36/48A61K38/03A61K38/07A61Q7/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,324,821
App. No.
16/259,074
Granted
Jun 10, 2025
Kind
B2
Abstract

A composition for promoting hair growth comprises hinoki oil, red clover extract, and a peptide. The hinoki oil can comprise from about 0.01% to about 5% by weight of the composition, the red clover extract can comprise from about 1 ppmw to about 1,000 ppmw of the composition, and the peptide can comprise from about 0.01 ppmw to about 500 ppmw of the composition.

Claims (19)

1. A method of preparing a composition for the treatment of alopecia, the method comprising:

mixing a plurality of ingredients into a carrier fluid to form a composition, wherein the composition comprises:

hinoki oil, wherein the hinoki oil comprises from about 0.02% to about 5% by weight of the composition;

a red clover extract, and wherein the red clover extract comprises from about 0.1 ppmw to about 1000 ppmw of the composition, wherein the red clover extract is extracted from red clover using an organic solvent; and

a peptide, wherein the peptide comprises from about 0.01 ppmw to about 1000 ppmw by weight of the composition,

wherein the composition has a therapeutically effective amount of the hinoki oil, the red clover extract, and the peptide suitable for treating a subject having alopecia.

2. The method of claim 1 , wherein the red clover extract comprises biochanin A.

3. The method of claim 1 , wherein the red clover extract comprises from about 1 ppmw to about 500 ppmw of the composition.

4. The method of claim 1 , wherein the hinoki oil comprises from about 0.05% to about 0.4% by weight of the composition.

5. The method of claim 1 , wherein the peptide comprises from about 0.01 ppmw to about 100 ppmw of the composition.

6. The method of claim 1 , wherein the peptide comprises at least one peptide selected from the group consisting of: tripeptide-1, acetyl hexapeptide-8, acetyl dipeptide-1, caproyl tetrapeptide-3, carnosine, glutathione, marine oligopeptide, marine oligopeptide, palmitoyl oligopeptide, human oligopeptide-1 (EGF), acetyl tetrapeptide-3, palmitoyl tetrapeptide-7, palmitoyl hexapeptide-14, pentapeptide-3, nonapeptide-1, acetyl hexapeptide, hexapeptide-11, SH-polypeptide-15, hexanoyl dipeptide-3, acetyl octapeptide-3, palmitoyl tripeptide-5, palmitoyl dipeptide-5, palmitoyl dipeptide-6, acetyl tetrapetide-2, and myristoyl pentapeptide-17.

7. The method of claim 1 , wherein the peptide is acetyl tetrapeptide-3.

8. The method of claim 1 , wherein the composition further comprises rosemary oil.

9. The method of claim 1 , wherein the composition further comprises tea tree oil.

10. The method of claim 1 , wherein the composition is in the form of at least one of a shampoo, a conditioner, or a foamed liquid.

11. The method of claim 1 , wherein the carrier fluid is an alcohol free carrier fluid.

12. The method of claim 1 , wherein the peptide comprises a tetrapeptide.

13. The method of claim 1 , wherein the peptide comprises acetyl tetrapeptide-5.

14. The method of claim 1 , further comprising: administering to the subject having alopecia the therapeutically effective amount of the composition.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2019
From: STOTTLEMYRE, DENNY E.; REYNOLDS, RONALD DALE
To: THE BEAUTY CARTEL, LLC.
Reel/Frame 048159/0001 →
Continuity (3)
Continuation 14763747
Provisional Application 61758618 · Jan 30, 2013
Related Publication 20190151385A1 · May 23, 2019
References Cited (31)
US 6184247B1 · Schneider · 2001 [cited by applicant]
US 6579516B1 · Mansouri · 2003 [cited by applicant]
US 7081258B2 · Hwang et al. · 2006 [cited by applicant]
US 7507719B2 · Pinel et al. · 2009 [cited by applicant]
US 8197865B2 · Glynn et al. · 2012 [cited by applicant]
US 8227426B2 · Gupta et al. · 2012 [cited by applicant]
US 10226495B2 · Stottlemyre · 2019 [cited by examiner]
US 20040213859A1 · Zelickson · 2004 [cited by applicant]
US 20120052032A1 · Yamaki · 2012 [cited by applicant]
US 20140135372A1 · Farber · 2014 [cited by applicant]
US 20150359830A1 · Stottlemyer et al. · 2015 [cited by applicant]
US 20170157021A1 · Traynor · 2017 [cited by examiner]
US 20170216164A1 · Traynor · 2017 [cited by examiner]
US 20170216165A1 · Traynor · 2017 [cited by examiner]
CN 101697949A · 2010 [cited by applicant]
FR 2882256A1 · 2006 [cited by examiner]
KR 691791B1 · 2007 [cited by examiner]
WO WO9407454A1 · 1994 [cited by examiner]
WO WO0032620A1 · 2000 [cited by examiner]
WO WO0211675A2 · 2002 [cited by examiner]
WO 2005002608A1 · 2005 [cited by applicant]
WO 2014120793A1 · 2014 [cited by applicant]
Lee et al. (“The essential oils of Chamaecyparis obtusa promote hair growth through the induction of vascular endothelial growth factor gene”, website article https://www.sciencedirect.com/science/article/pii/S0367326X0… [cited by examiner]
Evans, B. A. J., et al., “Inhibition of 5α-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids,” Journal of Endocrinology, 1995, pp. 295-302, vol. 147. [cited by applicant]
Foreign communication from a related counterpart application—International Search Report and Written Opinion, PCT/US2014/013631, May 20, 2014, 12 pages. [cited by applicant]
Foreign communication from a related counterpart application—International Preliminary Report on Patentability, PCT/US2014/013631, Aug. 4, 2015, 9 pages. [cited by applicant]
Lee, Geun-Shik, et al., “The essential oils of Chamaecyparis obtusa promote hair growth through the induction of vascular endothelial growth factor gene,” Fitoterapia, 2010, pp. 17-24, vol. 81, Elsevier B.V. [cited by applicant]
Loing, Estelle, et al., “A new strategy to modulate alopecia using a combination of two specific and unique ingredients,” Journal of Cosmetic Science, Jan./Feb. 2013, pp. 45-58, vol. 64. [cited by applicant]
Lucas Meyer Cosmetics technical file entitled “Capixyl™,” www.lucasmeyercosmetics.com, pp. 1-45. [cited by applicant]
Park, Young-Ok, et al. “The Effects of Chamaecyparis Obtusa Oil on the Activities of Enzyme Relevant to Hair Growth,” J. Kor. Soc. Cosm., 2008, pp. 355-364, vol. 14, No. 2. [cited by applicant]
South African Pharmaceutical & Cosmetic Review, “Hair loss solution,” http://www.pharmacos.co.za/personal-care/37-hair-care/903-capixyl-the-new-hair-loss-solution, Jun. 25, 2012, 2 pages. [cited by applicant]